A

Axsome Therapeutics
D

AXSM

91.870
USD
-1.87
(-1.99%)
مغلق
حجم التداول
26,988
الربح لكل سهم
-0
العائد الربحي
-
P/E
-14
حجم السوق
4,452,238,483
أصول ذات صلة
    A
    ACAD
    0.035
    (0.20%)
    17.560 USD
    AMGN
    AMGN
    2.84
    (1.05%)
    272.25 USD
    BIIB
    BIIB
    -0.660
    (-0.47%)
    140.580 USD
    B
    BMRN
    0.260
    (0.42%)
    61.570 USD
    I
    INCY
    -0.500
    (-0.69%)
    71.950 USD
    L
    LGND
    0.560
    (0.50%)
    111.690 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    S
    SRPT
    1.070
    (0.91%)
    118.040 USD
    VRTX
    VRTX
    4.97
    (1.19%)
    422.10 USD
    المزيد
الأخبار المقالات

العنوان: Axsome Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.